References

Brogan P, Bose A, Burgner D Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.. BMJ. 2002; 86:286-90 http//adc.bmj.com/content/86/4/286

Burns J, Glodé MP Kawasaki Syndrome. Lancet. 2004; 364:(9433)533-44

2005. http//www.biomedcentral.com/1471-2431/5/14 (accesses 30 August 2012)

Gordon J, Kahn A, Burns J When Children With Kawasaki Disease Grow Up.. J Am Coll Cardiol.. 2009; 54:(21)1911-120

Gregory P, Ward ALondon: Elsevier-Mosby; 2010

Hiew T, Cheng H ECG Abnormalities in Kawasaki disease and their value in predicting coronory artery aneurysms. Sing Med J. 1992; 33:262-7 http//smj.sma.org.sg/3303/3303a8.pdf

Joint Royal Colleges Service Liaison Committee. 2006. http//www.jrcalc.org.uk (accessed 30 August 2012)

King W, Schlieper A, Birdi N The effect of Kawasaki disease on cognition and behavior.. Arch Pediatr Adolesc Med. 2000; 154:(5)463-8

Kawasaki Disease Foundation. 2012. http//www.kfoundation.org (accessed 30 August 2012)

Bilateral Facial Nerve Palsy in Kawasaki Disease.. 2009. http//www.annals.edu.sg/pdf/38VolNo8Aug2009/V38N8p737.pdf (accessed 30 August 2012)

Matsubara T, Mason W, Kashani I Gastrointestinal haemorrhage complicating aspirin therapy in acute Kawasaki disease.. 1996; 128:(5pt1)701-3

Structure and function of matrix metalloproteinases and TIMPs.. 2005. http//cardiovascres.oxfordjournals.org/content/69/3/562.full.pdf+html (accessed 30 August 2012)

National Institute for Clinical Excellence. 2007. http//www.nice.org.uk/nicemedia/live/11010/30523/30523.pdf (accessed 30 August 2012)

Randomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease.. 2007. http//www.nejm.org/doi/full/10.1056/NEJMoa061235 (accessed 30 August 2012)

Rowley AH, Shulman ST Pathogenesis and management of Kawasaki disease.. Expert Rev Anti Infect Ther. 2010; 8:(2)197-203

The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases’. 2006. http//adc.bmj.com/content/91/10/847.short (accessed 30 August 2012)

Taubert K, Shulman S Kawasaki Disease. Am Fam Physician. 1999; 59:(11)3093-102

Tizard E Complications of Kawasaki disease.. Current Paediatrics. 2005; 15:62-8

Tortora G, Derrickson B, 12th. Chicago: RR Donnelley Publishing; 2009

Pre-hospital recognition of Kawaski disease: a guide for paramedics

09 September 2012
Volume 4 · Issue 9

Affecting children, predominantly those under the age of five, Kawaski disease (KD) is one of the main causes of heart abnormalities in children in the UK and USA—older children and teenagers can also contract KD, though such cases are very rare. KD promotes virus–like symptoms which can lead to inflammation in the blood vessels, arteries, veins and capillaries of the patient. Although there has been extensive research into this potentially fatal illness, the cause is still unknown, despite many hypotheses having been put forward over the years.

Statistics show that approximately eight in 100 000 children have Kawasaki disease (KD) within the UK, with the majority of cases being in boys (BUPA, 2010). Affecting children under the age of five, KD is one of the main causes of heart abnormalities in children in the UK and USA (Brogan et al, 2002), although older children and teenagers can contract KD, though such cases are very rare (Kawasaki Disease foundation, 2012).

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed